Clinical trials
Carcinoma, Merkel Cell trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Recruiting | 2 |
| Unknown status | 2 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| Incyte Corporation | 2 |
| Philogen S.p.A. | 2 |
| 4SC AG | 1 |
| Checkpoint Therapeutics, Inc. | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Kartos Therapeutics, Inc. | 1 |
| Marengo Therapeutics, Inc. | 1 |
| Merck KGaA, Darmstadt, Germany | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Merkel Cell | 19 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Melanoma | 6 |
| Carcinoma, Hepatocellular | 5 |
| Small Cell Lung Carcinoma | 5 |
| Triple Negative Breast Neoplasms | 5 |
| Head and Neck Neoplasms | 4 |
| Mesothelioma | 4 |
| Neoplasms | 4 |
| Stomach Neoplasms | 4 |
Trials
Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.